Discovery and development of a new class of potent, selective, orally active oxytocin receptor antagonists.
Quattropani A, Dorbais J, Covini D, Pittet PA, Colovray V, Thomas RJ, Coxhead R, Halazy S, Scheer A, Missotten M, Ayala G, Bradshaw C, De Raemy-Schenk AM, Nichols A, Cirillo R, Tos EG, Giachetti C, Golzio L, Marinelli P, Church DJ, Barberis C, Chollet A, Schwarz MK.
Quattropani A, et al. Among authors: schwarz mk.
J Med Chem. 2005 Dec 1;48(24):7882-905. doi: 10.1021/jm050645f.
J Med Chem. 2005.
PMID: 16302826